OMEROS CORP (OMER) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $721.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $792.33M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $720.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $793.58M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $716.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $791.75M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $700.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $778.97M.
OMEROS CORP Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $721.00K | (m) | $792.33M | $-844.40M | $-51.35M | (m) | 3 month · $1.62M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $720.00K | (m) | $793.58M | $-857.63M | $-63.33M | (m) | 3 month · $1.89M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $716.00K | (m) | $791.75M | $-913.70M | $-121.23M | (m) | 12 month · $8.19M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $700.00K | (m) | $778.97M | $-1.00B | $-220.48M | (m) | 3 month · $1.94M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $599.00K | (m) | $739.95M | $-969.23M | $-228.69M | (m) | 3 month · $2.06M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $580.00K | (m) | $729.67M | $-943.80M | $-213.55M | (m) | 3 month · $2.45M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $580.00K | (m) | $727.16M | $-910.35M | $-182.61M | (m) | 12 month · $10.49M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $579.00K | $724.24M | (m) | $-878.99M | $-154.17M | 3 month · $2.64M | 3 month · $2.64M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $579.00K | $721.58M | (m) | $-846.75M | $-124.60M | 3 month · $2.77M | 3 month · $2.77M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $579.00K | $718.81M | (m) | $-790.71M | $-71.33M | 3 month · $2.66M | 3 month · $2.66M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $611.00K | $727.94M | $727.94M | $-753.53M | $-24.98M | 12 month · $11.65M | 12 month · $11.65M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $628.00K | $729.88M | (m) | $-744.46M | $-13.95M | 3 month · $3.23M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $628.00K | $726.59M | (m) | $-706.71M | $20.51M | 3 month · $2.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $628.00K | $723.73M | (m) | $-669.42M | $54.94M | 3 month · $2.95M | 3 month · $2.95M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $628.00K | $720.77M | (m) | $-635.72M | $85.68M | 12 month · $14.07M | 12 month · $14.07M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $627.00K | $717.51M | (m) | $-764.45M | $-46.31M | 3 month · $3.84M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $627.00K | $713.66M | (m) | $-746.99M | $-32.70M | 3 month · $3.07M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $627.00K | $710.59M | (m) | $-716.14M | $-4.92M | 3 month · $3.89M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $626.00K | $706.29M | (m) | $-683.13M | $23.78M | 12 month · $17.54M | (m) | (m) | (m) | 12 month · $241.00K | (m) | (m) |
| 2021-09-30 | (m) | $625.00K | $700.43M | (m) | $-963.75M | $-262.70M | 3 month · $5.69M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $624.00K | $694.13M | (m) | $-941.05M | $-246.30M | 3 month · $3.12M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $622.00K | $689.88M | (m) | $-912.46M | $-221.96M | 3 month · $3.27M | (m) | (m) | (m) | 3 month · $241.00K | (m) | (m) |
| 2020-12-31 | (m) | $616.00K | $751.30M | (m) | $-872.67M | $-120.75M | 12 month · $14.77M | (m) | 12 month · $-22.07M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $616.00K | $747.46M | (m) | $-835.40M | $-87.33M | 3 month · $3.82M | (m) | 3 month · $-22.07M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $545.00K | $635.12M | (m) | $-796.94M | $-161.27M | 3 month · $3.82M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $545.00K | $631.23M | (m) | $-763.64M | $-131.86M | 3 month · $3.48M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $542.00K | $625.05M | (m) | $-734.61M | $-109.02M | 12 month · $13.79M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $495.00K | $564.98M | (m) | $-705.39M | $-139.91M | 3 month · $3.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $492.00K | $558.16M | (m) | $-688.92M | $-130.27M | 3 month · $3.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $490.00K | (m) | $552.96M | $-674.47M | $-121.02M | 3 month · $3.37M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $490.00K | $549.48M | $549.48M | $-650.12M | $-100.16M | 12 month · $11.71M | (m) | 12 month · $55.66M | (m) | (m) | 12 month · $-12.93M | 12 month · $1.42M |
| 2018-09-30 | $0.00 | $490.00K | (m) | $537.10M | $-626.59M | $-89.00M | 3 month · $2.93M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $485.00K | (m) | $530.34M | $-587.12M | $-56.30M | 3 month · $3.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $483.00K | (m) | $523.72M | $-553.42M | $-29.21M | 3 month · $2.97M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $482.00K | (m) | $520.07M | $-523.37M | $-2.81M | 12 month · $12.69M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $0.00 | $480.00K | (m) | $515.55M | $-506.82M | $9.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $0.00 | $444.00K | (m) | $444.04M | $-499.33M | $-54.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $0.00 | $439.00K | (m) | $436.42M | $-484.98M | $-48.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $438.00K | (m) | $432.00M | $-469.89M | $-37.45M | 12 month · $13.58M | (m) | (m) | (m) | (m) | (m) | 12 month · $758.00K |
| 2016-09-30 | $0.00 | $429.00K | (m) | $427.05M | $-450.25M | $-22.77M | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $758.00K |
| 2016-06-30 | (m) | $393.00K | (m) | $386.90M | $-436.29M | $-48.99M | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $758.00K |
| 2016-03-31 | $0.00 | $391.00K | (m) | $382.55M | $-423.68M | $-40.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $380.00K | (m) | $376.53M | $-403.14M | $-26.23M | 12 month · $9.58M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $0.00 | $380.00K | (m) | $373.93M | $-383.32M | $-9.00M | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $0.00 |
| 2015-06-30 | $0.00 | $379.00K | (m) | $370.95M | $-363.39M | $7.93M | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $0.00 |
| 2015-03-31 | $0.00 | $378.00K | (m) | $368.18M | $-346.71M | $21.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | $342.00K | (m) | $285.05M | $-328.05M | $-42.65M | 12 month · $8.92M | (m) | (m) | (m) | (m) | (m) | 12 month · $863.00K |
| 2014-09-30 | (m) | $340.00K | (m) | $280.40M | $-307.33M | $-26.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $340.00K | (m) | $278.06M | $-289.01M | $-10.61M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $339.00K | (m) | $275.89M | $-271.01M | $5.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $0.00 | $304.00K | (m) | $235.69M | $-254.37M | $-18.38M | 12 month · $6.25M | (m) | (m) | (m) | (m) | (m) | 12 month · $41.00K |
| 2013-09-30 | (m) | $298.00K | (m) | $228.34M | $-252.53M | $-23.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $298.00K | (m) | $226.10M | $-238.66M | $-12.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $259.00K | (m) | $208.94M | $-225.07M | $-15.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $0.00 | $259.00K | (m) | $207.79M | $-214.58M | $-6.53M | 12 month · $4.28M | (m) | (m) | (m) | 12 month · $2.20M | (m) | 12 month · $511.00K |
| 2012-09-30 | (m) | $259.00K | (m) | $205.76M | $-206.84M | $-820.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $225.00K | (m) | $172.81M | $-193.57M | $-20.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $225.00K | (m) | $172.12M | $-185.03M | $-12.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $224.00K | (m) | $170.35M | $-176.13M | $-5.55M | 12 month · $1.93M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $223.00K | (m) | $169.79M | (m) | $4.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $222.00K | (m) | $169.21M | (m) | $10.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $219.00K | (m) | $167.84M | $-147.59M | $20.47M | 12 month · $2.18M | (m) | (m) | (m) | (m) | (m) | 12 month · $994.00K |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | $43.15M | 12 month · $1.49M | (m) | (m) | 12 month · $-902.00K | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | $-91.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |